May 9, 2025
TOPLINE: Pain, nausea, and vomiting were the most frequently documented symptoms preceding unplanned acute care visits in patients with cancer, new research showed. Women, individuals from […]
May 9, 2025
In the 11 years since it was approved for the treatment of melanoma, pembrolizumab (Keytruda) has become the go-to for adjuvant or neoadjuvant therapy for advanced […]
May 9, 2025
TOPLINE: Short-interval CT demonstrated spontaneous resolution of consolidation in more than 50% of lung cancer screening participants, while persistent consolidation showed a 29.8% risk for malignancy. […]
May 8, 2025
The US Food and Drug Administration (FDA) has granted accelerated approval of combination avutometinib and defactinib (Avmapki Fakzynja Co-pack, Verastem, Inc.) for the treatment of certain […]
May 8, 2025
In the treatment of non-Hodgkin lymphoma with CD19 chimeric antigen receptor (CAR) T-cell therapy, baseline kidney function did not appear to be associated with an increased […]
May 8, 2025
Despite the rising incidence rates of breast cancer among younger women, advances in treatment and detection appear to reduce breast cancer mortality in this population. New […]
May 7, 2025
TOPLINE: Sarcopenia, a hallmark of cancer cachexia, is associated with poor outcomes in chimeric antigen receptor (CAR) T-cell therapy, which can exacerbate muscle loss through inflammatory […]
May 7, 2025
TOPLINE: After a median follow-up of 99 months, salvage high-dose chemotherapy and autologous stem cell transplantation (sHDCT/ASCT) showed no survival benefit compared with continuous lenalidomide/dexamethasone in […]
May 7, 2025
TOPLINE: A study of 162,500 patients with uterine cancer found that survival rates varied significantly by race and geographic location, with Black patients experiencing the worst […]